ANCA相关性血管炎住院患者肺炎发生率与院内死亡:西班牙全国登记研究
肺炎与更高的ICU入住率、更长住院时间和更高院内死亡率相关,且为院内死亡的独立预测因素。
要点
- AAV住院患者中约10.3%合并肺炎,肺炎组院内死亡率14.9% vs 无肺炎组4.4%。
- 肺炎是院内死亡的独立预测因素(OR 1.97,95%CI 1.63-2.37,P<0.001)。
- 病毒性肺炎在研究期间显著增加(IRR 1.46,95%CI 1.38-1.54,P<0.001),COVID-19期间达峰。
核心结论
- AAV住院患者中约十分之一发生肺炎,肺炎与更高的院内死亡风险和ICU使用相关。
研究设计与样本
- 西班牙全国性回顾性分析,纳入2016至2023年住院出院记录,以ICD-10编码识别AAV住院及合并肺炎。
主要发现
- 肺炎组ICU入住率13.5% vs 无肺炎组6.5%,住院中位天数22天 vs 17天,院内死亡率14.9% vs 4.4%(均P<0.001)。
- AAV院内死亡率随时间显著增加(IRR 1.13/年,P<0.001)。
- 病毒性肺炎在2021-2022年COVID-19期间激增,2023年下降,但整个研究期间显著增加(IRR 1.46,95%CI 1.38-1.54,P<0.001)。
- 院内病死率随极端SOI升高而急剧上升(27.1% vs 18.7%,P<0.001)。
- 肺炎为死亡的独立预测因素(OR 1.97,95%CI 1.63-2.37,P<0.001),更高ROM与死亡风险强相关。
关键数值与推荐
- 疾病严重程度采用severity of illness(SOI)和risk of mortality(ROM)指数分类。
临床怎么用
- 对AAV住院患者应积极预防感染并早期治疗肺炎,以降低院内死亡和ICU使用风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the incidence, predictors and impact of pneumonia among hospitalized patients with ANCA-associated vasculitis (AAV). METHODS: A nationwide retrospective analysis of Spanish hospital discharges (2016-2023) identified all AAV admissions and coexisting pneumonia using ICD-10 codes. Outcomes included pneumonia incidence, intensive care unit (ICU) utilization, length of stay, temporal trends, in-hospital mortality and case fatality rate (CFR). Illness severity was classified using the severity of illness (SOI) and risk of mortality (ROM) indices. Multivariable logistic regression was used to identify independent predictors of in-hospital mortality. RESULTS: Among 12 378 AAV hospitalizations, 1280 (10.3%) had pneumonia. Pneumonia was associated with higher ICU admission rates (13.5% vs 6.5%), longer stays (median 22 vs 17 days), and greater in-hospital mortality (14.9% vs 4.4%) than those without pneumonia (all P < 0.001). In-hospital AAV mortality increased significantly over time (incidence rate ratio [IRR], 1.13 per year; P < 0.001). Viral pneumonia cases in AAV surged during the COVID-19 pandemic (2021-2022), declined by 2023, and showed a significant overall increase across the study period (IRR, 1.46; 95% CI: 1.38, 1.54; P < 0.001). In-hospital CFR rose sharply with extreme SOI (27.1% vs 18.7%; P < 0.001). Pneumonia was an independent predictor of death (odds ratio 1.97; 95% CI: 1.63, 2.37; P < 0.001), and a higher ROM was strongly associated with mortality risk. CONCLUSION: Around 1 in 10 hospitalizations with AAV develop pneumonia, which is associated with higher odds of in-hospital death and greater ICU utilization. Pneumonia is strongly associated with worse outcomes in AAV, supporting the need for proactive infection prevention and early treatment in AAV.
引用
- Cordero-Pérez FJ, Puertas-Miranda D, Arribas Pérez L, et al. Pneumonia and in-hospital mortality in ANCA-associated vasculitis: a nationwide population-based registry study in Spain. Rheumatology (Oxford). 2026. PMID: 42191671. doi:10.1093/rheumatology/keag276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。